MPP’s 2026-2030 strategy builds on 15 years of experience to ensure that health innovations reach people in LMICs sooner, more equitably and more sustainably. By combining public health-oriented licensing, technology transfer and strong partnerships, MPP will continue to turn innovation into access, and access into impact.
Our mission is to increase equitable access to innovative medicines and other health technologies through public health-oriented voluntary licensing and technology transfer.
MPP’s 2026-2030 strategy builds on 15 years of experience to ensure that health innovations reach people in LMICs sooner, more equitably and more sustainably.
Founder & Funder since 2010